Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Reaching un-drugable intracellular targets with the long arm of antibodies.

Scheinberg DA, Dao T, Liu C.

Oncotarget. 2013 May;4(5):647-8. No abstract available.

2.

-ximab this and -zumab that! Has the magic bullet arrived in the new millennium of medicine and science?

Ballow M.

J Allergy Clin Immunol. 2005 Oct;116(4):738-43. Review. No abstract available.

PMID:
16210044
3.

T-cell receptor-based immunointervention in autoimmune diseases. Therapeutic use of monoclonal antibodies.

Chatenoud L, Bach JF.

Immunol Ser. 1993;59:101-16. Review. No abstract available.

PMID:
7681694
5.

T cell antigen receptor antibodies.

Kung P.

Nature. 1987 Dec 3-9;330(6147):501-2.

PMID:
2446144
6.

[Monoclonal hybrid antibodies. New perspectives for basic research and tumor therapy].

Zepp F, Staerz UD.

Monatsschr Kinderheilkd. 1992 Oct;140(10):745-52. Review. German.

PMID:
1435794
7.

From the guest editor: The rise of CAR therapy: the CD19 paradigm, and beyond. Introduction.

Sadelain M.

Cancer J. 2014 Mar-Apr;20(2):105-6. doi: 10.1097/PPO.0000000000000042. No abstract available.

PMID:
24667953
8.

Monoclonal antibodies and human tumours: pathological and clinical aspects.

Neville AM, Gusterson BA.

Eur J Cancer Clin Oncol. 1985 Mar;21(3):355-69. No abstract available.

PMID:
2408896
9.

The emerging therapeutic role of antibody mixtures.

Robak T.

Expert Opin Biol Ther. 2013 Jul;13(7):953-8. doi: 10.1517/14712598.2013.799133. Epub 2013 May 7.

PMID:
23646883
10.

Genetic re-targeting of T lymphocyte specificity.

Bolhuis RL, Gratama JW.

Gene Ther. 1998 Sep;5(9):1153-5. No abstract available.

11.

Monoclonal antibodies. Use in detection and treatment of cancer.

Rabin BS.

Postgrad Med. 1986 Jan;79(1):293-8, 303.

PMID:
2417219
12.

From monoclonal antibodies to chimeric antigen receptors for the treatment of human malignancies.

Caruana I, Diaconu I, Dotti G.

Semin Oncol. 2014 Oct;41(5):661-6. doi: 10.1053/j.seminoncol.2014.08.005. Epub 2014 Aug 12. Review.

13.

Activation of human T cells obtained pre- and post-interleukin-2 (IL-2) therapy by anti-CD3 monoclonal antibody plus IL-2: implications for combined in vivo treatment.

Weil-Hillman G, Schell K, Segal DM, Hank JA, Sosman JA, Sondel PM.

J Immunother (1991). 1991 Aug;10(4):267-77.

PMID:
1834166
14.
15.
16.

Growth factor receptors as targets for antitumor therapy with monoclonal antibodies.

Mendelsohn J.

Prog Allergy. 1988;45:147-60. Review. No abstract available.

PMID:
3064094
17.

Using monoclonal antibodies to stimulate antitumor cellular immunity.

Durrant LG, Pudney VA, Spendlove I.

Expert Rev Vaccines. 2011 Jul;10(7):1093-106. doi: 10.1586/erv.11.33. Review.

PMID:
21806402
18.

Distinct epitopes on the T cell antigen receptor of HPB-ALL tumor cells identified by monoclonal antibodies.

Lanier LL, Ruitenberg JJ, Allison JP, Weiss A.

J Immunol. 1986 Oct 1;137(7):2286-92.

PMID:
2428866
19.

Cell membrane molecule I-J transduces a negative signal for early T-cell activation induced via the TCR.

Asano Y, Nakayama T, Kishimoto H, Komuro T, Sano K, Utsunomiya N, Nakanishi M, Tada T.

Cold Spring Harb Symp Quant Biol. 1989;54 Pt 2:683-8. No abstract available.

PMID:
2484249
20.

Targeted cellular immunotherapy with bifunctional antibodies.

Nelson H.

Cancer Cells. 1991 May;3(5):163-72. Review.

PMID:
1832553

Supplemental Content

Support Center